NextVein LLC has announced an amendment to its previous securities offering, aiming to raise a total of $2 million. This update is significant as it reflects the company’s ongoing efforts to secure necessary capital in a competitive landscape.

Founded in New York, NextVein LLC focuses on the health care sector, specifically under the category of Other Health Care. The company filed its most recent amendment on November 3, 2026, under accession number 0002134718-26-000106. The filing indicates that NextVein has already raised $1,202,350 of the total offering amount, leaving $797,650 still available for investment.

The filing states, "Rule 506(b) provides a 'safer harbor' for a private offering," which highlights the regulatory framework under which the company is operating. The amendment also specifies that the minimum investment accepted is $25,000, and it has not engaged any non-accredited investors in this round of funding.

This fundraising effort may impact various stakeholders, including the company’s current investors and potential new investors looking to capitalize on NextVein's growth prospects. The company has reported a total of 10 investors already involved in this offering.

NextVein LLC is led by CEO Ron Goldman, who signed the amendment on November 2, 2026. The filing does not specify what steps the company will take next in its fundraising journey, leaving investors and market watchers awaiting further updates.